Apixaban for PrOphyLaxis of thromboemboLic Outcomes in COVID-19

Clinical trial NCT04746339 · TERMINATED

Trial details

NCT number: NCT04746339
Sponsor: Brazilian Clinical Research Institute
Status: TERMINATED
Phase: Phase 4
Study type: INTERVENTIONAL

Covid19 Thrombosis

Start date: 2021-03-04
Primary completion: 2022-05-13
Enrollment: 411

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.